All Stories

  1. The role of IL-10 in microbiome-associated immune modulation and disease tolerance

    Article • Cytokine, October 2015, Elsevier

    Professor Joaquin (Quim) Madrenas

  2. Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis

    Article • Nature Immunology, March 2015, Springer Science + Business Media

    Professor Joaquin (Quim) Madrenas

  3. Stomatin-Like Protein 2 Is Required forIn VivoMitochondrial Respiratory Chain Supercomplex Formation and Optimal Cell Function

    Article • Molecular and Cellular Biology, March 2015, ASM Journals

    Professor Joaquin (Quim) Madrenas

  4. Is Antigenic Sin Always “Original?” Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu

    Article • PLoS Pathogens, March 2015, PLOS

    Professor Joaquin (Quim) Madrenas

  5. Uncoupling of Pro- and Anti-Inflammatory Properties of Staphylococcus aureus

    Article • Infection and Immunity, February 2015, ASM Journals

    Professor Joaquin (Quim) Madrenas

  6. Lymphocytes: Antigen-Induced Gene Activation

    Article • September 2013, Wiley

    Professor Joaquin (Quim) Madrenas

  7. Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality

    Article • PLoS ONE, August 2013, PLOS

    Professor Joaquin (Quim) Madrenas

  8. Thinking Outside the Mouse: Organism-Environment Interaction and Human Immunology

    Article • July 2013, Springer Science + Business Media

    Professor Joaquin (Quim) Madrenas

  9. The broad landscape of immune interactions with Staphylococcus aureus: From commensalism to lethal infections

    Article • Burns, May 2013, Elsevier

    Professor Joaquin (Quim) Madrenas

  10. Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study

    Article • BMC Nephrology, February 2013, Springer Science + Business Media

    Professor Joaquin (Quim) Madrenas, Professor Guido Filler

  11. Down-Regulation of CTLA-4 by HIV-1 Nef Protein

    Article • PLoS ONE, January 2013, PLOS

    Professor Joaquin (Quim) Madrenas

  12. Identification of Multimolecular Complexes and Supercomplexes in Compartment-Selective Membrane Microdomains

    Article • January 2013, Elsevier

    Professor Joaquin (Quim) Madrenas

  13. Evolving Bacterial Envelopes and Plasticity of TLR2-Dependent Responses: Basic Research and Translational Opportunities

    Article • Frontiers in Immunology, January 2013, Frontiers

    Professor Joaquin (Quim) Madrenas

  14. High molecular weight polysaccharides are key immunomodulators in North American ginseng extracts: Characterization of the ginseng genetic signature in primary human immune cells

    Article • Journal of Ethnopharmacology, June 2012, Elsevier

    Professor Joaquin (Quim) Madrenas

  15. Mitochondrial and Plasma Membrane Pools of Stomatin-Like Protein 2 Coalesce at the Immunological Synapse during T Cell Activation

    Article • PLoS ONE, May 2012, PLOS

    Professor Joaquin (Quim) Madrenas

  16. Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease

    Article • Clinical Biochemistry, April 2011, Elsevier

    Professor Joaquin (Quim) Madrenas, Professor Guido Filler

  17. TLR2 signalling: At the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus

    Article • The International Journal of Biochemistry & Cell Biology, July 2010, Elsevier

    Professor Joaquin (Quim) Madrenas

  18. CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice

    Article • Arthritis & Rheumatism, June 2010, Wiley

    Professor Joaquin (Quim) Madrenas, Dr Subrata Chakrabarti

  19. Plasticity of TLR2-mediated Regulation of Adaptive T Cell Responses: Learning from Staphylococcus Aureus

    Article • Clinical Immunology, January 2010, Elsevier

    Professor Joaquin (Quim) Madrenas

  20. Plasticity of TLR2-mediated Regulation of Adaptive T Cell Responses: Learning from Staphylococcus aureus

    Article • Clinical Immunology, January 2010, Elsevier

    Professor Joaquin (Quim) Madrenas

  21. The TCR β-chain CDR2 Loop Governs Vβ-specificity by Bacterial Superantigens

    Article • Clinical Immunology, January 2010, Elsevier

    Professor Joaquin (Quim) Madrenas

  22. Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5

    Article • Cancer Cell, August 2009, Elsevier

    Professor Joaquin (Quim) Madrenas

  23. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome

    Article • Nature Reports Stem Cells, May 2009, Springer Science + Business Media

    Dr David E Heinrichs, Professor Joaquin (Quim) Madrenas

  24. Structure-Function analysis of the CTLA-4 interaction with PP2A

    Article • BMC Immunology, January 2009, Springer Science + Business Media

    Professor Joaquin (Quim) Madrenas

  25. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

    Article • Journal of Cellular and Molecular Medicine, October 2008, Wiley

    Professor Joaquin (Quim) Madrenas

  26. Characterization of oligomers induced by inverse agonists of CTLA-4

    Article • Immunology Letters, September 2008, Elsevier

    Professor Joaquin (Quim) Madrenas

  27. RIP2 Is Required for NOD Signaling But Not for Th1 Cell Differentiation and Cellular Allograft Rejection

    Article • American Journal of Transplantation, June 2008, Wiley

    Professor Joaquin (Quim) Madrenas

  28. The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection

    Article • Expert Review of Molecular Diagnostics, May 2008, Taylor & Francis

    Professor Joaquin (Quim) Madrenas

  29. F.21. Immune Regulation of Experimental Autoimmune Encephalomyelitis (EAE) by RIP2-dependent Modulation of NF-κB Signaling

    Article • Clinical Immunology, January 2008, Elsevier

    Professor Joaquin (Quim) Madrenas

  30. Molecular Determinants of Inverse Agonist Activity of Biologicals Targeting CTLA-4

    Article • The Journal of Immunology, September 2007, The American Association of Immunologists

    Professor Joaquin (Quim) Madrenas

  31. Crystal Structure of the Streptococcal Superantigen SpeI and Functional Role of a Novel Loop Domain in T Cell Activation by Group V Superantigens

    Article • Journal of Molecular Biology, April 2007, Elsevier

    Professor Joaquin (Quim) Madrenas

  32. T Cell Signalling Induced by Bacterial Superantigens

    Article • January 2007, Karger Publishers

    Professor Joaquin (Quim) Madrenas

  33. Bacterial Superantigens Bypass Lck-Dependent T Cell Receptor Signaling by Activating a Gα11-Dependent, PLC-β-Mediated Pathway

    Article • Immunity, July 2006, Elsevier

    Professor Joaquin (Quim) Madrenas

  34. A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION

    Article • Annual Review of Immunology, April 2006, Annual Reviews

    Professor Joaquin (Quim) Madrenas

  35. Su.48. Stomatin-Like Protein 2 Stabilizes Tcr-Dependent Signalling Microclusters in Effector T-Cells

    Article • Clinical Immunology, January 2006, Elsevier

    Professor Joaquin (Quim) Madrenas

  36. Su.80. Up-Regulation of Rip2 Expression During Peritonitis Correlates with Clinical Outcome

    Article • Clinical Immunology, January 2006, Elsevier

    Professor Joaquin (Quim) Madrenas

  37. Giving credit where credit is due: John Hunter and the discovery of erythrocyte sedimentation rate

    Article • The Lancet, December 2005, Elsevier

    Professor Joaquin (Quim) Madrenas

  38. Lymphocytes: Antigen-induced Gene Activation

    Article • September 2005, Wiley

    Professor Joaquin (Quim) Madrenas

  39. Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis

    Article • Clinical & Experimental Immunology, March 2005, Wiley

    Professor Joaquin (Quim) Madrenas

  40. Polycationic lipids inhibit the pro-inflammatory response to LPS

    Article • Immunology Letters, January 2005, Elsevier

    Professor Joaquin (Quim) Madrenas, Dr Bhagirath Singh

  41. Lck Is Required for Activation-Induced T Cell Death after TCR Ligation with Partial Agonists

    Article • The Journal of Immunology, January 2004, The American Association of Immunologists

    Professor Joaquin (Quim) Madrenas

  42. Superantigen Stimulation Reveals the Contribution of Lck to Negative Regulation of T Cell Activation

    Article • The Journal of Immunology, December 2003, The American Association of Immunologists

    Professor Joaquin (Quim) Madrenas

  43. Viewpoint: Therapeutic Implications of CTLA-4 Compartmentalization

    Article • American Journal of Transplantation, June 2003, Wiley

    Professor Joaquin (Quim) Madrenas

  44. A SLAT in the Th2 Signalosome

    Article • Immunity, April 2003, Elsevier

    Professor Joaquin (Quim) Madrenas

  45. Lymphocytes: Antigen-Induced Gene Activation

    Article • April 2001, Wiley

    Professor Joaquin (Quim) Madrenas

  46. The role of ezrin in T-cell receptor-dependent signaling

    Article • Transplantation Proceedings, February 2001, Elsevier

    Professor Joaquin (Quim) Madrenas

  47. Generation of partial agonist ligands of the T-cell receptor by engineering of antibodies against CD3

    Article • Transplantation Proceedings, February 2001, Elsevier

    Professor Joaquin (Quim) Madrenas

  48. STABILIZATION OF T CELL RECEPTOR-DEPENDENT SIGNALLING COMPLEXES BY EZRIN.

    Article • Transplantation, April 2000, Wolters Kluwer Health

    Professor Joaquin (Quim) Madrenas

  49. Prevention of Diabetes Mellitus in the Non-obese Diabetic Mouse Strain with Monoclonal Antibodies Against the CD45RB Molecule

    Article • Autoimmunity, January 2000, Taylor & Francis

    Professor Joaquin (Quim) Madrenas

  50. Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression

    Article • European Journal of Immunology, January 2000, Wiley

    Professor Joaquin (Quim) Madrenas

  51. Cytoskeletal disruption induces T cell apoptosis by a caspase-3 mediated mechanism

    Article • Life Sciences, November 1999, Elsevier

    Professor Joaquin (Quim) Madrenas

  52. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes

    Article • European Journal of Immunology, May 1999, Wiley

    Professor Joaquin (Quim) Madrenas

  53. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes

    Article • European Journal of Immunology, May 1999, Wiley

    Professor Joaquin (Quim) Madrenas

  54. EVIDENCE FOR NEGATIVE SELECTION OF ALLOREACTIVE T CELLS IN THE THYMUS OF ALLOGRAFT RECIPIENTS

    Article • Transplantation, April 1999, Wolters Kluwer Health

    Professor Joaquin (Quim) Madrenas

  55. PARTIAL AGONISTS OF THE T CELL RECEPTOR ACTIVATE THE Ras-MAPK PATHWAY IN A LAT-INDEPENDENT MANNER

    Article • Transplantation, April 1999, Wolters Kluwer Health

    Professor Joaquin (Quim) Madrenas

  56. Surgical technique for vascularized thymus transplantation in mice

    Article • Microsurgery, January 1999, Wiley

    Professor Joaquin (Quim) Madrenas

  57. Differential signalling by variant ligands of the T cell receptor and the kinetic model of T cell activation

    Article • Life Sciences, January 1999, Elsevier

    Professor Joaquin (Quim) Madrenas

  58. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease

    Article • Immunology Today, October 1998, Elsevier

    Professor Joaquin (Quim) Madrenas

  59. Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor

    Article • The Journal of Experimental Medicine, May 1998, Rockefeller University Press

    Professor Joaquin (Quim) Madrenas

  60. Vascular Thymus Transplantation in Mice

    Article • January 1998, Springer Science + Business Media

    Professor Joaquin (Quim) Madrenas

  61. The Efficiency of CD4 Recruitment to Ligand-engaged TCR Controls the Agonist/Partial Agonist Properties of Peptide–MHC Molecule Ligands

    Article • The Journal of Experimental Medicine, January 1997, Rockefeller University Press

    Professor Joaquin (Quim) Madrenas

  62. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation

    Article • Seminars in Immunology, April 1996, Elsevier

    Professor Joaquin (Quim) Madrenas

  63. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

    Article • Science, January 1995, American Association for the Advancement of Science

    Professor Joaquin (Quim) Madrenas

  64. Alternatively spliced, germline Jα11-2-Cα mRNAs are the predominant T cell receptor α transcripts in mouse kidney

    Article • Molecular Immunology, September 1994, Elsevier

    Professor Joaquin (Quim) Madrenas

  65. The molecular immunology of acute rejection: an overview

    Article • Transplant Immunology, March 1993, Elsevier

    Professor Joaquin (Quim) Madrenas

  66. Complement-Dependent Cytotoxicity for Negative Selection at the mRNA Level

    Article • Immunological Investigations, January 1992, Taylor & Francis

    Professor Joaquin (Quim) Madrenas

  67. The mechanism of action of cyclosporine: A perspective for the 90's

    Article • Clinical Biochemistry, February 1991, Elsevier

    Professor Joaquin (Quim) Madrenas

  68. Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritis

    Article • Kidney International, February 1991, Elsevier

    Professor Joaquin (Quim) Madrenas

  69. REGULATION OF MHC TRANSCRIPTION

    Article • Transplantation, November 1990, Wolters Kluwer Health

    Professor Joaquin (Quim) Madrenas

  70. An Alternative Approach for Statistical Analysis of Kidney Transplant Data: Multivariate Analysis of Single-Center Experience

    Article • American Journal of Kidney Diseases, December 1988, Elsevier

    Professor Joaquin (Quim) Madrenas

  71. Anterior tibial compartment syndrome secondary to systemic capillary leak syndrome.

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 1987, BMJ

    Professor Joaquin (Quim) Madrenas

  72. Digoxin-Like Immunoreacting Activity in the Serum of Patients on Regular Hemodialysis

    Article • January 1986, Karger Publishers

    Professor Joaquin (Quim) Madrenas

  73. Extra-Uterine Müllerian Carcinosarcoma

    Article • Acta Obstetricia Et Gynecologica Scandinavica, January 1986, Wiley

    Professor Joaquin (Quim) Madrenas